Partial ablation of the pancreas of Sprague Dawley® rats by focused ultrasound reveals no significant adverse effects on glycometabolism function.

MLA

Ao, Lan, et al. “Partial Ablation of the Pancreas of Sprague Dawley® Rats by Focused Ultrasound Reveals No Significant Adverse Effects on Glycometabolism Function.” Ultrasonics, vol. 80, Sept. 2017, pp. 113–18. EBSCOhost, https://doi.org/10.1016/j.ultras.2017.05.006.

APA

Ao, L., Hu, N., Hu, H. X., Liu, Q., Zhao, Z. H., Liu, L. X., Wu, J. R., Li, F. Q., & Fang, L. Q. (2017). Partial ablation of the pancreas of Sprague Dawley® rats by focused ultrasound reveals no significant adverse effects on glycometabolism function. Ultrasonics, 80, 113–118. https://doi.org/10.1016/j.ultras.2017.05.006

Chicago

Ao, Lan, Na Hu, Hai Xia Hu, Qing Liu, Zi Hao Zhao, Long Xing Liu, Jun Ru Wu, Fa Qi Li, and Liao Qiong Fang. 2017. “Partial Ablation of the Pancreas of Sprague Dawley® Rats by Focused Ultrasound Reveals No Significant Adverse Effects on Glycometabolism Function.” Ultrasonics 80 (September): 113–18. doi:10.1016/j.ultras.2017.05.006.